As of 2026-04-05, the Intrinsic Value of HCA Healthcare Inc (HCA) is 610.21 USD. This HCA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 471.84 USD, the upside of HCA Healthcare Inc is 29.30%.
The range of the Intrinsic Value is 485.03 - 798.23 USD
Based on its market price of 471.84 USD and our intrinsic valuation, HCA Healthcare Inc (HCA) is undervalued by 29.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 485.03 - 798.23 | 610.21 | 29.3% |
| DCF (Growth 10y) | 653.49 - 1,024.88 | 802.46 | 70.1% |
| DCF (EBITDA 5y) | 421.65 - 589.72 | 515.60 | 9.3% |
| DCF (EBITDA 10y) | 584.04 - 798.91 | 697.89 | 47.9% |
| Fair Value | 527.82 - 527.82 | 527.82 | 11.86% |
| P/E | 396.85 - 541.94 | 475.69 | 0.8% |
| EV/EBITDA | 243.90 - 373.06 | 309.23 | -34.5% |
| EPV | 1,122.05 - 1,444.09 | 1,283.07 | 171.9% |
| DDM - Stable | 248.60 - 490.54 | 369.57 | -21.7% |
| DDM - Multi | 379.18 - 594.58 | 464.07 | -1.6% |
| Market Cap (mil) | 105,489.27 |
| Beta | 0.39 |
| Outstanding shares (mil) | 223.57 |
| Enterprise Value (mil) | 150,941.27 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.56% |
| Cost of Debt | 5.01% |
| WACC | 6.45% |